Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2002 2
2003 1
2004 3
2005 2
2006 2
2007 11
2008 16
2009 18
2010 24
2011 30
2012 18
2013 25
2014 29
2015 41
2016 29
2017 32
2018 39
2019 33
2020 40
2021 51
2022 36
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Results by year

Filters applied: . Clear all
Page 1
Regulatory T Cells in GVHD Therapy.
Guo WW, Su XH, Wang MY, Han MZ, Feng XM, Jiang EL. Guo WW, et al. Front Immunol. 2021 Jun 18;12:697854. doi: 10.3389/fimmu.2021.697854. eCollection 2021. Front Immunol. 2021. PMID: 34220860 Free PMC article. Review.
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial.
Pan J, Tan Y, Wang G, Deng B, Ling Z, Song W, Seery S, Zhang Y, Peng S, Xu J, Duan J, Wang Z, Yu X, Zheng Q, Xu X, Yuan Y, Yan F, Tian Z, Tang K, Zhang J, Chang AH, Feng X. Pan J, et al. Among authors: feng x. J Clin Oncol. 2021 Oct 20;39(30):3340-3351. doi: 10.1200/JCO.21.00389. Epub 2021 Jul 29. J Clin Oncol. 2021. PMID: 34324392 Clinical Trial.
Wang S, Feng X. Wang S, et al. Among authors: feng x. Urology. 2022 Feb;160:175. doi: 10.1016/j.urology.2021.04.075. Urology. 2022. PMID: 35216698 No abstract available.
Wang S, Feng X. Wang S, et al. Among authors: feng x. Urology. 2022 Feb;160:174. doi: 10.1016/j.urology.2021.04.073. Urology. 2022. PMID: 35216696 No abstract available.
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia.
Pan J, Niu Q, Deng B, Liu S, Wu T, Gao Z, Liu Z, Zhang Y, Qu X, Zhang Y, Liu S, Ling Z, Lin Y, Zhao Y, Song Y, Tan X, Zhang Y, Li Z, Yin Z, Chen B, Yu X, Yan J, Zheng Q, Zhou X, Gao J, Chang AH, Feng X, Tong C. Pan J, et al. Among authors: feng x. Leukemia. 2019 Dec;33(12):2854-2866. doi: 10.1038/s41375-019-0488-7. Epub 2019 May 20. Leukemia. 2019. PMID: 31110217 Clinical Trial.
460 results